Cargando…
067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
Autores principales: | Hillary, T., Van Laethem, A., Castelijns, F., Vermeire, S., Geldof, J., Ferrante, M., De Vlam, K., Verschueren, P., Sabino, J., Lobaton, T., Lapeere, H., Lambert, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497030/ http://dx.doi.org/10.1016/j.jid.2021.08.069 |
Ejemplares similares
-
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study
por: Geldof, Jeroen, et al.
Publicado: (2023) -
34296 Introduction of BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
por: Hillary, Tom, et al.
Publicado: (2022) -
P067 Abstract Withdrawn
Publicado: (2021) -
New biologics and small molecules in inflammatory bowel disease: an
update
por: Sabino, João, et al.
Publicado: (2019) -
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
por: Grine, L., et al.
Publicado: (2020)